Canopy Growth Corporation has filed a prospectus supplement on May 13, 2024, to update and supplement information in its previous prospectus dated May 13, 2024, with new details from its Current Report on Form 8-K. The supplement pertains to the offering and sale of 1,086,279 common shares by selling securityholders, which were issued on April 30, 2024, following amendments to initial option agreements related to the acquisition of Wana Wellness and other entities. The amendments include a reduction in the exercise price for the Wana Option and the issuance of common shares worth US$10,667,259.78. Additionally, Canopy Growth has entered into an eighth amendment to the Floating Share Arrangement Agreement with Canopy USA, LLC and Acreage Holdings, Inc., extending the Exercise Outside Date and the date for exercising...Show More

Canopy Growth Corporation has filed a prospectus supplement on May 13, 2024, to update and supplement information in its previous prospectus dated May 13, 2024, with new details from its Current Report on Form 8-K. The supplement pertains to the offering and sale of 1,086,279 common shares by selling securityholders, which were issued on April 30, 2024, following amendments to initial option agreements related to the acquisition of Wana Wellness and other entities. The amendments include a reduction in the exercise price for the Wana Option and the issuance of common shares worth US$10,667,259.78. Additionally, Canopy Growth has entered into an eighth amendment to the Floating Share Arrangement Agreement with Canopy USA, LLC and Acreage Holdings, Inc., extending the Exercise Outside Date and the date for exercising the Canopy Call Option to June 17, 2024. The completion of the Floating Share Arrangement is subject to certain conditions, and there is no certainty that the acquisition of Acreage will be completed. Canopy Growth's common shares are traded on the Toronto Stock Exchange and the Nasdaq Global Select Market under the symbols 'WEED' and 'CGC' respectively.